| Accession Number | 0002114309-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Clinical Development | Ordinary Shares | โ | Aug 30, 2026 | Exercise/Conversion | 9,382 | โ | โ | 307,483 | Direct | โ | View Details | |
EVP, Clinical Development | Ordinary Shares | โ | Aug 31, 2026 | Sale | 3,282 | $0.79 | $2,592.78 | 304,201 | Direct | โ | View Details | |
EVP, Clinical Development | Restricted Share Units | Derivative | Aug 30, 2026 | Exercise/Conversion | 4,079 | $0.00 | $0.00 | 28,558 | Direct | โ | View Details |